Let's be clear. Oil companies brought in $200 billion in profit last year, while high energy prices meant that many families struggled to keep food on the table.
Alexandria Ocasio-Cortez
The Public Record
Alexandria Ocasio-Cortez is an American politician and activist serving as the U.S. Representative for New York's 14th congressional district since January 3, 2019. A member of the Democratic Party, she gained national attention for her progressive policies and advocacy on issues such as climate change, healthcare, and economic inequality. Ocasio-Cortez is known for her grassroots campaigning and her ability to mobilize young voters, making her a prominent figure in the progressive wing of the party.
The current arguments characterizing energy independence lose credibility when you discover that the United States is currently exporting 50 percent more oil and gas than we did in 2019.
Offshore wind should not just learn from the mistakes of the oil field, but the good that comes from the health industry by adopting the promise of do no harm before they do good.
It is my understanding that, currently, you all do not have, and consequently we do not have, real-data on overdoses happening in the United States, including non-fatal overdoses.
It is important to have that data so we can get people the help that they need sooner than wait for them to die.
Dr. Gupta, how does the ONDCP utilize its unique cross Agency structure to effectively combat the addiction crisis?
By linking oil and gas to wind, you create a distrust in wind because coastal communities remember how industry stole the land, destroyed it, and the water.
Some of the earlier testimony that we saw today also referred, and I am glad to hear that there was agreement on this, that the public should not bear the costs of decommissioning.
The stakes are high. The health of the planet and the well-being of the workforce and future generations hang in the balance.
Today's hearing is an opportunity to examine the Federal offshore oil and gas program.
Fabulous. And are there any changes the Committee should consider making through the ONDCP reauthorization process to improve the office's ability to coordinate drug control policy and action across the Federal Government?





